The Dawn of Bespoke Oncology: Phase 3 Trial Results Reveal How Personalized mRNA Vaccines Are Rewriting the Rules of Melanoma Treatment
Executive Overview In what oncologists are calling a watershed moment for modern medicine, pharmaceutical giants Merck and Moderna have unveiled the definitive...
